Miriam Kidron, Chief Scientific Officer at ORAMED PHARMACEUTICALS INC. (ORMP), sold 105,628 shares at $6.33 ($669K) on 2017-04-19, disclosed to the SEC on 2017-04-19.
Open-market sale of $669k ORMP by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.33 | 52,814 | $334K | 50.0% |
| 2 | $6.33 | 52,814 | $334K | 50.0% |
| Total | $6.33 avg | 105,628 | $669K | 100% |
| Filing → |
| ORMP | SELL | 2015-12-31 | $445K | — | Filing → |
| ORMP | SELL | 2014-09-12 | $267K | — | Filing → |
| ORMP | SELL | 2014-04-03 | $1.7M | — | Filing → |